Cell signalling by reactive lipid species: New concepts and molecular mechanisms

Biochemical Journal

Volumn 442, Issue 3, 2012, Pages 453-464

  Higdon, Ashlee ^a   Diers, Anne R ^a,b   Oh, Joo Yeun ^a   Landar, Aimee ^a   Darley Usmar, Victor M ^a  

^a University of Alabama at Birmingham   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Electrophile responsive proteome; Kelch like ECH associated protein 1 (Keap1); Lipid peroxidation; Nuclear factor erythroid 2 related factor (Nrf2); Protein modification; Reactive lipid species (RLS)

Indexed keywords

GLUTATHIONE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; OXIDIZING AGENT; REACTIVE LIPID SPECIES; THIOL; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

AUTOPHAGY; CELL DEATH; CELLULAR DISTRIBUTION; COVALENT BOND; ELECTROPHILICITY; ENZYME ACTIVITY; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CELL DEATH; HUMANS; LIPID METABOLISM; LIPID PEROXIDATION; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84857833776     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111752     Document Type: Review

References (196)

1. Pratico, D., Lawson, J. A., Rokach, J. and FitzGerald, G. A. (2001) The isoprostanes in biology and medicine. Trends Endocrinol. Metab. 12, 243-247 (Pubitemid 33714213)
2. Gaut, J. P. and Heinecke, J. W. (2001) Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc. Med. 11, 103-112 (Pubitemid 33070332)
3. Milne, G. L., Musiek, E. S. and Morrow, J. D. (2005) F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10, S10-S23
4. Marwah, S. S., Blann, A. D., Rea, C., Phillips, J. D., Wright, J. and Bareford, D. (2002) Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis. Am. J. Hematol. 69, 144-146 (Pubitemid 34111170)
5. Yin, H. and Porter, N. A. (2005) New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid. Redox Signaling 7, 170-184 (Pubitemid 40187935)
6. Poon, H. F., Calabrese, V., Scapagnini, G. and Butterfield, D. A. (2004) Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J. Gerontol. A Biol. Sci. Med. Sci. 59, 478-493 (Pubitemid 38649940)
7. Morrow, J. D. (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25, 279-286
8. Volkel, W., Sicilia, T., Pahler, A., Gsell, W., Tatschner, T., Jellinger, K., Leblhuber, F., Riederer, P., Lutz, W. K. and Gotz, M. E. (2006) Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease. Neurochem. Int. 48, 679-686
9. Musiek, E. S., Breeding, R. S., Milne, G. L., Zanoni, G., Morrow, J. D. and McLaughlin, B. (2006) Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J. Neurochem. 97, 1301-1313 (Pubitemid 43725570)
10. Patel, M., Liang, L. P., Hou, H., Williams, B. B., Kmiec, M., Swartz, H. M., Fessel, J. P. and Roberts, II, L. J. (2008) Seizure-induced formation of isofurans: novel products of lipid peroxidation whose formation is positively modulated by oxygen tension. J. Neurochem. 104, 264-270 (Pubitemid 350265056)
11. Chen, J., Henderson, G. I. and Freeman, G. L. (2001) Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J. Mol. Cell. Cardiol. 33, 1919-1927 (Pubitemid 33097271)
12. Landar, A., Giles, N. M., Zmijewski, J. W., Watanabe, N., Oh, J. Y. and Darley-Usmar, V. M. (2006) Modification of lipids by reactive oxygen and nitrogen species: the oxy-nitroxy-lipidome and its role in redox cell signaling. Future Lipidol. 1, 203-211
13. Codreanu, S. G., Zhang, B., Sobecki, S. M., Billheimer, D. D. and Liebler, D. C. (2009) Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol. Cell. Proteomics 8, 670-680
14. Mochizuki, M., Ishii, Y., Itoh, K., Iizuka, T., Morishima, Y., Kimura, T., Kiwamoto, T., Matsuno, Y., Hegab, A. E., Nomura, A. et al. (2005) Role of 15-deoxyΔ(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am. J. Respir. Crit. Care Med. 171, 1260-1266 (Pubitemid 40740733)
15. Rudolph, T. K. and Freeman, B. A. (2009) Transduction of redox signaling by electrophile-protein reactions. Sci. Signaling 2, re7
16. Cooper, C. E., Patel, R. P., Brookes, P. S. and Darley-Usmar, V. M. (2002) Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem. Sci. 27, 489-492 (Pubitemid 35279586)
17. Jones, D. P. (2008) Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 295, C849-C868
18. Lopez-Sanchez, L. M., Muntane, J., de la Mata, M. and Rodriguez-Ariza, A. (2009) Unraveling the S-nitrosoproteome: tools and strategies. Proteomics 9, 808-818
19. Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A. and Shelton, M. D. (2008) Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid. Redox Signaling 10, 1941-1988
20. Rhee, S. G., Chae, H. Z. and Kim, K. (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biol. Med. 38, 1543-1552
21. Ceaser, E. K., Moellering, D. R., Shiva, S., Ramachandran, A., Landar, A., Venkartraman, A., Crawford, J., Patel, R., Dickinson, D. A., Ulasova, E. et al. (2004) Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem. Soc. Trans. 32, 151-155 (Pubitemid 38283038)
22. Dickinson, D. A., Darley-Usmar, V. M. and Landar, A. (2006) The covalent advantage: a new paradigm for cell signaling by thiol reactive lipid oxidation products. In Redox Proteomics: from Protein Modifications to Cellular Dysfunction and Diseases (Dalle-Donne, I. Scalone, A. and Butterfield, D. A., eds), pp. 345-367, John Wiley &Sons, Indianapolis
23. Stamatakis, K. and Perez-Sala, D. (2006) Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes. Ann. N.Y. Acad. Sci. 1091, 548-570 (Pubitemid 47092266)
24. Hong, F., Sekhar, K. R., Freeman, M. L. and Liebler, D. C. (2005) Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280, 31768-31775 (Pubitemid 41291926)
25. Rachakonda, G., Xiong, Y., Sekhar, K. R., Stamer, S. L., Liebler, D. C. and Freeman, M. L. (2008) Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem. Res. Toxicol. 21, 705-710 (Pubitemid 351498046)
26. Tsujita, T., Li, L., Nakajima, H., Iwamoto, N., Nakajima-Takagi, Y., Ohashi, K., Kawakami, K., Kumagai, Y., Freeman, B. A., Yamamoto, M. and Kobayashi, M. (2011) Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. Genes Cells 16, 46-57
27. Breyer, R. M., Bagdassarian, C. K., Myers, S. A. and Breyer, M. D. (2001) Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661-690 (Pubitemid 32385902)
28. Reilly, M. P., Lawson, J. A. and FitzGerald, G. A. (1998) Eicosanoids and isoeicosanoids: indices of cellular function and oxidant stress. J. Nutr. 128, 434S-438S (Pubitemid 28090398)
29. Prigge, S. T., Boyington, J. C., Faig, M., Doctor, K. S., Gaffney, B. J. and Amzel, L. M. (1997) Structure and mechanism of lipoxygenases. Biochimie 79, 629-636 (Pubitemid 28043450)
30. Sanchez-Gomez, F. J., Gayarre, J., Avellano, M. I. and Perez-Sala, D. (2007) Direct evidence for the covalent modification of glutathione-S- transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. Arch. Biochem. Biophys. 457, 150-159 (Pubitemid 46048697)
31. Kobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y. and Yamamoto, M. (2009) The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29, 493-502
32. Di Napoli, M. and Papa, F. (2003) The proteasome system and proteasome inhibitors in stroke: controlling the inflammatory response. Curr. Opin. Invest. Drugs 4, 1333-1342 (Pubitemid 38100579)
33. Oh, J. Y., Giles, N., Landar, A. and Darley-Usmar, V. (2008) Accumulation of 15-deoxy-Δ(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem. J. 411, 297-306 (Pubitemid 351580182)
34. Tappel, A. L. (1953) The inhibition of hematin-catalyzed oxidations by α-tocopherol. Arch. Biochem. Biophys. 47, 223-225
35. Niki, E., Yoshida, Y., Saito, Y. and Noguchi, N. (2005) Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun. 338, 668-676 (Pubitemid 41540614)
36. O'Donnell, V. B., Maskrey, B. and Taylor, G. W. (2009) Eicosanoids: generation and detection in mammalian cells. Methods Mol. Biol. 462, 5-23
37. Davies, S. S., Amarnath, V. and Roberts, II, L. J. (2004) Isoketals: highly reactive γ-ketoaldehydes formed from the H2-isoprostane pathway. Chem. Phys. Lipids 128, 85-99 (Pubitemid 38167379)
38. O'Donnell, V. B. and Freeman, B. A. (2001) Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ. Res. 88, 12-21 (Pubitemid 32064077)
39. Baker, P. R., Lin, Y., Schopfer, F. J., Woodcock, S. R., Groeger, A. L., Batthyany, C., Sweeney, S., Long, M. H., Iles, K. E., Baker, L. M. et al. (2005) Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 280, 42464-42475 (Pubitemid 43023219)
40. Scher, J. U. and Pillinger, M. H. (2005) 15d-PGJ2: the anti-inflammatory prostaglandin? Clin. Immunol. 114, 100-109
41. Trostchansky, A., Souza, J. M., Ferreira, A., Ferrari, M., Blanco, F., Trujillo, M., Castro, D., Cerecetto, H., Baker, P. R., O'Donnell, V. B. and Rubbo, H. (2007) Synthesis, isomer characterization, and anti-inflammatory properties of nitroarachidonate. Biochemistry 46, 4645-4653 (Pubitemid 46625519)
42. Jacobs, A. T. and Marnett, L. J. (2010) Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc. Chem. Res. 43, 673-683
43. Vila, A., Tallman, K. A., Jacobs, A. T., Liebler, D. C., Porter, N. A. and Marnett, L. J. (2008) Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 21, 432-444
44. Petersen, D. R. and Doorn, J. A. (2004) Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radical Biol. Med. 37, 937-945 (Pubitemid 39164576)
45. Stamatakis, K., Sanchez-Gomez, F. J. and Perez-Sala, D. (2006) Identification of novel protein targets for modification by 15-deoxy-Δ12, 14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. J. Am. Soc. Nephrol. 17, 89-98
46. Porter, N. A., Caldwell, S. E. and Mills, K. A. (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30, 277-290
47. Gebicki, J. M., Nauser, T., Domazou, A., Steinmann, D., Bounds, P. L. and Koppenol, W. H. (2010) Reduction of protein radicals by GSH and ascorbate: potential biological significance. Amino Acids 39, 1131-1137
48. Fritz, K. S. and Petersen, D. R. (2011) Exploring the biology of lipid peroxidation-derived protein carbonylation. Chem. Res. Toxicol. 24, 1411-1419
49. O'Donnell, V. B., Chumley, P. H., Hogg, N., Bloodsworth, A., Darley-Usmar, V. M. and Freeman, B. A. (1997) Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with α-tocopherol. Biochemistry 36, 15216-15223 (Pubitemid 27527986)
50. Waddington, E. I., Croft, K. D., Sienuarine, K., Latham, B. and Puddey, I. B. (2003) Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates. Atherosclerosis 167, 111-120 (Pubitemid 36255642)
51. Qiu, H., Gabrielsen, A., Agardh, H. E., Wan, M., Wetterholm, A., Wong, C. H., Hedin, U., Swedenborg, J., Hansson, G. K., Samuelsson, B. et al. (2006) Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. U.S.A. 103, 8161-8166 (Pubitemid 43801069)
52. Cipollone, F. (2005) COX-2 and prostaglandins in atherosclerosis. Lupus 14, 756-759
53. Stocker, R. and Keaney, Jr, J. F. (2004) Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478 (Pubitemid 39302636)
54. Reeder, B. J., Svistunenko, D. A., Cooper, C. E. and Wilson, M. T. (2004) The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid. Redox Signaling 6, 954-966 (Pubitemid 39434932)
55. Grunwald, E. W. and Richards, M. P. (2006) Mechanisms of heme protein-mediated lipid oxidation using hemoglobin and myoglobin variants in raw and heated washed muscle. J. Agric. Food Chem. 54, 8271-8280 (Pubitemid 44785414)
56. Kanner, J., German, J. B. and Kinsella, J. E. (1987) Initiation of lipid peroxidation in biological systems. Crit. Rev. Food Sci. Nutr. 25, 317-364
57. 2 activated metmyoglobin. Lipids 20, 625-628
58. Kanner, J. and Harel, S. (1985) Initiation of membranal lipid peroxidation by activated metmyoglobin and methemoglobin. Arch. Biochem. Biophys. 237, 314-321 (Pubitemid 15144885)
59. Galaris, D., Sevanian, A., Cadenas, E. and Hochstein, P. (1990) Ferrylmyoglobin-catalyzed linoleic acid peroxidation. Arch. Biochem. Biophys. 281, 163-169 (Pubitemid 20232887)
60. Radi, R., Beckman, J. S., Bush, K. M. and Freeman, B. A. (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487
61. Darley-Usmar, V. M., Hogg, N., O'Leary, V. J., Wilson, M. T. and Moncada, S. (1992) The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radical Res. Commun. 17, 9-20
62. Moncada, S. and Higgs, E. A. (2006) The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147, S193-S201 (Pubitemid 43077277)
63. Al Ghouleh, I., Khoo, N. K., Knaus, U. G., Griendling, K. K., Touyz, R. M., Thannickal, V. J., Barchowsky, A., Nauseef, W. M., Kelley, E. E., Bauer, P. M. et al. (2011) Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radical Biol. Med. 51, 1271-1288
64. Patel, R. P., Diczfalusy, U., Dzeletovic, S., Wilson, M. T. and Darley-Usmar, V. M. (1996) Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J. Lipid Res. 37, 2361-2371 (Pubitemid 26427450)
65. Moore, K. P., Darley-Usmar, V., Morrow, J. and Roberts, II, L. J. (1995) Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ. Res. 77, 335-341
66. Cui, T., Schopfer, F. J., Zhang, J., Chen, K., Ichikawa, T., Baker, P. R., Batthyany, C., Chacko, B. K., Feng, X., Patel, R. P. et al. (2006) Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281, 35686-35698 (Pubitemid 46041299)
67. O'Donnell, V. B., Eiserich, J. P., Chumley, P. H., Jablonsky, M. J., Krishna, N. R., Kirk, M., Barnes, S., Darley-Usmar, V. M. and Freeman, B. A. (1999) Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem. Res. Toxicol. 12, 83-92 (Pubitemid 29048836)
68. Stables, M. J. and Gilroy, D. W. (2011) Old and new generation lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 50, 35-51
69. Ueno, N., Murakami, M., Tanioka, T., Fujimori, K., Tanabe, T., Urade, Y. and Kudo, I. (2001) Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. J. Biol. Chem. 276, 34918-34927
70. Garavito, R. M. and Mulichak, A. M. (2003) The structure of mammalian cyclooxygenases. Annu. Rev. Biophys. Biomol. Struct. 32, 183-206 (Pubitemid 37056227)
71. Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L. and Simmons, D. L. (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 88, 2692-2696 (Pubitemid 21916484)
72. Hinz, B. and Brune, K. (2002) Cyclooxygenase-2: 10 years later. J. Pharmacol. Exp. Ther. 300, 367-375
73. Pham, H., Shafer, L. M. and Slice, L. W. (2006) CREB-dependent cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression is mediated by protein kinase C and calcium. J. Cell. Biochem. 98, 1653-1666 (Pubitemid 44141867)
74. Parfenova, H., Balabanova, L. and Leffler, C. W. (1998) Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells. Am. J. Physiol. 274, C72-C81
75. Upmacis, R. K., Deeb, R. S. and Hajjar, D. P. (1999) Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry 38, 12505-12513
76. Upmacis, R. K., Deeb, R. S. and Hajjar, D. P. (2006) Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediators 80, 1-14 (Pubitemid 44056286)
77. Schildknecht, S., Bachschmid, M. and Ullrich, V. (2005) Peroxynitrite provides the peroxide tone for PGHS-2-dependent prostacyclin synthesis in vascular smooth muscle cells. FASEB J. 19, 1169-1171 (Pubitemid 40946454)
78. Yamada, T., Komoto, J., Watanabe, K., Ohmiya, Y. and Takusagawa, F. (2005) Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2). J. Mol. Biol. 348, 1163-1176 (Pubitemid 40602374)
79. Watanabe, K., Urade, Y., Mader, M., Murphy, C. and Hayaishi, O. (1994) Identification of beta-trace as prostaglandin D synthase. Biochem. Biophys. Res. Commun. 203, 1110-1116 (Pubitemid 2127858)
80. Matsumoto, H., Naraba, H., Murakami, M., Kudo, I., Yamaki, K., Ueno, A. and Oh-ishi, S. (1997) Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 230, 110-114 (Pubitemid 27210253)
81. Tokugawa, Y., Kunishige, I., Kubota, Y., Shimoya, K., Nobunaga, T., Kimura, T., Saji, F., Murata, Y., Eguchi, N., Oda, H. et al. (1998) Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma. Biol. Reprod. 58, 600-607 (Pubitemid 28099129)
82. Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh, S. and Kudo, I. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792
83. Lin, Y. Z., Deng, H. and Ruan, K. H. (2000) Topology of catalytic portion of prostaglandin I2 synthase: identification by molecular modeling-guided site-specific antibodies. Arch. Biochem. Biophys. 379, 188-197 (Pubitemid 30637453)
84. Groeger, A. L., Cipollina, C., Cole, M. P., Woodcock, S. R., Bonacci, G., Rudolph, T. K., Rudolph, V., Freeman, B. A. and Schopfer, F. J. (2010) Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat. Chem. Biol. 6, 433-441
85. Musiek, E. S., Brooks, J. D., Joo, M., Brunoldi, E., Porta, A., Zanoni, G., Vidari, G., Blackwell, T. S., Montine, T. J., Milne, G. L. et al. (2008) Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J. Biol. Chem. 283, 19927-19935
86. Leff, A. R. (2001) Regulation of leukotrienes in the management of asthma: biology and clinical therapy. Annu. Rev. Med. 52, 1-14
87. Rouzer, C. A. and Samuelsson, B. (1985) On the nature of the 5-lipoxygenase reaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors. Proc. Natl. Acad. Sci. U.S.A. 82, 6040-6044 (Pubitemid 16223894)
88. Yamamoto, S. (1991) 'Enzymatic' lipid peroxidation: reactions of mammalian lipoxygenases. Free Radical Biol. Med. 10, 149-159
89. Suzuki, H., Kishimoto, K., Yoshimoto, T., Yamamoto, S., Kanai, F., Ebina, Y., Miyatake, A. and Tanabe, T. (1994) Site-directed mutagenesis studies on the iron-binding domain and the determinant for the substrate oxygenation site of porcine leukocyte arachidonate 12-lipoxygenase. Biochim. Biophys. Acta 1210, 308-316 (Pubitemid 24048874)
90. Nelson, M. J., Batt, D. G., Thompson, J. S. and Wright, S. W. (1991) Reduction of the active-site iron by potent inhibitors of lipoxygenases. J. Biol. Chem. 266, 8225-8229 (Pubitemid 21906500)
91. Weitzel, F. and Wendel, A. (1993) Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. J. Biol. Chem. 268, 6288-6292 (Pubitemid 23099321)
92. Holzhutter, H. G., Wiesner, R., Rathmann, J., Stosser, R. and Kuhn, H. (1997) A kinetic model for the interaction of nitric oxide with a mammalian lipoxygenase. Eur. J. Biochem. 245, 608-616 (Pubitemid 27223892)
93. Spanbroek, R., Grabner, R., Lotzer, K., Hildner, M., Urbach, A., Ruhling, K., Moos, M. P., Kaiser, B., Cohnert, T. U., Wahlers, T. et al. (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 100, 1238-1243 (Pubitemid 36183986)
94. Yokomizo, T., Izumi, T. and Shimizu, T. (2001) Leukotriene B4: metabolism and signal transduction. Arch. Biochem. Biophys. 385, 231-241
95. Yokomizo, T., Uozumi, N., Takahashi, T., Kume, K., Izumi, T. and Shimizu, T. (1995) Leukotriene A4 hydrolase and leukotriene B4 metabolism. J. Lipid Mediators Cell Signaling 12, 321-332
96. Hankin, J. A., Jones, D. N. and Murphy, R. C. (2003) Covalent binding of leukotriene A4 to DNA and RNA. Chem. Res. Toxicol. 16, 551-561 (Pubitemid 36514514)
97. Orning, L., Gierse, J., Duffin, K., Bild, G., Krivi, G. and Fitzpatrick, F. A. (1992) Mechanism-based inactivation of leukotriene A4 hydrolase/ aminopeptidase by leukotriene A4. Mass spectrometric and kinetic characterization. J. Biol. Chem. 267, 22733-22739
98. Lepley, R. A. and Fitzpatrick, F. A. (1994) Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes. J. Biol. Chem. 269, 2627-2631
99. Goetzl, E. J., An, S. and Smith, W. L. (1995) Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9, 1051-1058
100. Hata, A. N. and Breyer, R. M. (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharm. Ther. 103, 147-166 (Pubitemid 39209041)
101. Perez-Sala, D., Cernuda-Morollon, E., Pineda-Molina, E. and Canada, F. J. (2002) Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins. Ann. N.Y. Acad. Sci. 973, 533-536 (Pubitemid 36125064)
102. Izumi, T., Yokomizo, T., Obinata, H., Ogasawara, H. and Shimizu, T. (2002) Leukotriene receptors: classification, gene expression, and signal transduction. J. Biochem. (Tokyo) 132, 1-6 (Pubitemid 34832263)
103. Johansson, A. S., Haeggstrom, J. Z. and Palmblad, J. (2011) Commonly used leukotriene B4 receptor antagonists possess intrinsic activity as agonists in human endothelial cells: effects on calcium transients, adhesive events and mediator release. Prostaglandins Leukotrienes Essent. Fatty Acids 84, 109-112
104. Ogasawara, H., Ishii, S., Yokomizo, T., Kakinuma, T., Komine, M., Tamaki, K., Shimizu, T. and Izumi, T. (2002) Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J. Biol. Chem. 277, 18763-18768 (Pubitemid 34952434)
105. Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D. S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z. et al. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789-793 (Pubitemid 29293175)
106. Hasegawa, S., Ichiyama, T., Hashimoto, K., Suzuki, Y., Hirano, R., Fukano, R. and Furukawa, S. (2010) Functional expression of cysteinyl leukotriene receptors on human platelets. Platelets 21, 253-259
107. Takasaki, J., Kamohara, M., Matsumoto, M., Saito, T., Sugimoto, T., Ohishi, T., Ishii, H., Ota, T., Nishikawa, T., Kawai, Y. et al. (2000) The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor. Biochem. Biophys. Res. Commun. 274, 316-322 (Pubitemid 30614317)
108. Diab, A., Deng, C., Smith, J. D., Hussain, R. Z., Phanavanh, B., Lovett-Racke, A. E., Drew, P. D. and Racke, M. K. (2002) Peroxisome proliferator-activated receptor-γagonist 15-deoxy-Δ(12,14)- prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168, 2508-2515 (Pubitemid 34171857)
109. Madrazo, J. A. and Kelly, D. P. (2008) The PPAR trio: regulators of myocardial energy metabolism in health and disease. J. Mol. Cell. Cardiol. 44, 968-975
110. Schopfer, F. J., Cipollina, C. and Freeman, B. A. (2011) Formation and signaling actions of electrophilic lipids. Chem. Rev. 111, 5997-6021
111. Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M. and FitzGerald, G. A. (2003) Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ. J. Clin. Invest. 112, 945-955
112. Ide, T., Egan, K., Bell-Parikh, L. C. and FitzGerald, G. A. (2003) Activation of nuclear receptors by prostaglandins. Thromb. Res. 110, 311-315 (Pubitemid 37329831)
113. Powell, W. S. (2003) 15-Deoxy-Δ12,14-PGJ2: endogenous PPARγ ligand or minor eicosanoid degradation product? J. Clin. Invest. 112, 828-830
114. Schopfer, F. J., Cole, M. P., Groeger, A. L., Chen, C. S., Khoo, N. K., Woodcock, S. R., Golin-Bisello, F., Motanya, U. N., Li, Y., Zhang, J. et al. (2010) Covalent peroxisome proliferator-activated receptor γ adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. J. Biol. Chem. 285, 12321-12333
115. Li, Y., Zhang, J., Schopfer, F. J., Martynowski, D., Garcia-Barrio, M. T., Kovach, A., Suino-Powell, K., Baker, P. R., Freeman, B. A., Chen, Y. E. and Xu, H. E. (2008) Molecular recognition of nitrated fatty acids by PPARγ . Nat. Struct. Mol. Biol. 15, 865-867
116. Landar, A., Oh, J. Y., Giles, N. M., Isom, A., Kirk, M., Barnes, S. and Darley-Usmar, V. (2006) A sensitive method for the quantitative measurement of protein thiol modification in response to oxidative stress. Free Radical Biol. Med. 40, 459-468 (Pubitemid 43139681)
117. Schaur, R. J. (2003) Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Aspects Med. 24, 149-159
118. Lopachin, R. M., Gavin, T., Decaprio, A. and Barber, D. S. (2011) Application of the hard and soft, acids and bases (HSAB) theory to toxicant-target interactions. Chem. Res. Toxicol., doi:10.1021/tx2003257
119. Carlson, R. M. (1990) Assessment of the propensity for covalent binding of electrophiles to biological substrates. Environ. Health Perspect. 87, 227-232
120. Schultz, T. W., Carlson, R. E., Cronin, M. T., Hermens, J. L., Johnson, R., O'Brien, P. J., Roberts, D. W., Siraki, A., Wallace, K. B. and Veith, G. D. (2006) A conceptual framework for predicting the toxicity of reactive chemicals: modeling soft electrophilicity. SAR QSAR Environ. Res. 17, 413-428 (Pubitemid 44277098)
121. Qing, W. G., Powell, K. L. and MacLeod, M. C. (1996) Kinetics of the reaction of a potential chemopreventive agent, 2,6-dithiopurine, and its major metabolite, 2,6-dithiouric acid, with multiple classes of electrophilic toxicants. Chem. Res. Toxicol. 9, 1298-1304 (Pubitemid 26403835)
122. Schultz, T. W. and Yarbrough, J. W. (2004) Trends in structure-toxicity relationships for carbonyl-containing α,β-unsaturated compounds. SAR QSAR Environ. Res. 15, 139-146 (Pubitemid 38390852)
123. Sanchez-Gomez, F. J., Cernuda-Morollon, E., Stamatakis, K. and Perez-Sala, D. (2004) Protein thiol modification by 15-deoxy-Δ12,14- prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol. Pharmacol. 66, 1349-1358 (Pubitemid 39411076)
124. Renedo, M., Gayarre, J., Garcia-Dominguez, C. A., Perez-Rodriguez, A., Prieto, A., Canada, F. J., Rojas, J. M. and Perez-Sala, D. (2007) Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. Biochemistry 46, 6607-6616 (Pubitemid 46870126)
125. Ricart, K. C., Bolisetty, S., Johnson, M. S., Perez, J., Agarwal, A., Murphy, M. P. and Landar, A. (2009) The permissive role of mitochondria in the induction of haem oxygenase-1 in endothelial cells. Biochem. J. 419, 427-436
126. Liu, S. and Hanzlik, R. P. (1992) Structure-activity relationships for inhibition of papain by peptide Michael acceptors. J. Med. Chem. 35, 1067-1075
127. Liu, X. W. and Sok, D. E. (2004) Inactivation of protein disulfide isomerase by alkylators including α,β-unsaturated aldehydes at low physiological pHs. Biol. Chem. 385, 633-637
128. Ying, J., Clavreul, N., Sethuraman, M., Adachi, T. and Cohen, R. A. (2007) Thiol oxidation in signaling and response to stress: detection and quantification of physiological and pathophysiological thiol modifications. Free Radical Biol. Med. 43, 1099-1108 (Pubitemid 47374443)
129. Mallis, R. J., Buss, J. E. and Thomas, J. A. (2001) Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem. J. 355, 145-153 (Pubitemid 32304245)
130. Martinez-Ruiz, A. and Lamas, S. (2004) Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch. Biochem. Biophys. 423, 192-199 (Pubitemid 38198228)
131. Saurin, A. T., Neubert, H., Brennan, J. P. and Eaton, P. (2004) Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc. Natl. Acad. Sci. U.S.A. 101, 17982-17987 (Pubitemid 40054061)
132. Biswas, S., Chida, A. S. and Rahman, I. (2006) Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem. Pharmacol. 71, 551-564 (Pubitemid 43121989)
133. Moran, L. K., Gutteridge, J. M. and Quinlan, G. J. (2001) Thiols in cellular redox signalling and control. Curr. Med. Chem. 8, 763-772 (Pubitemid 32427905)
134. Lopachin, R. M., Barber, D. S., Geohagen, B. C., Gavin, T., He, D. and Das, S. (2007) Structure-toxicity analysis of type-2 alkenes: in vitro neurotoxicity. Toxicol. Sci. 95, 136-146 (Pubitemid 44942784)
135. Chan, K., Poon, R. and O'Brien, P. J. (2008) Application of structure-activity relationships to investigate the molecular mechanisms of hepatocyte toxicity and electrophilic reactivity of α,β-unsaturated aldehydes. J. Appl. Toxicol. 28, 1027-1039
136. Levonen, A. L., Landar, A., Ramachandran, A., Ceaser, E. K., Dickinson, D. A., Zanoni, G., Morrow, J. D. and Darley-Usmar, V. M. (2004) Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378, 373-382 (Pubitemid 38367228)
137. Hong, F., Freeman, M. L. and Liebler, D. C. (2005) Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 18, 1917-1926 (Pubitemid 43023050)
138. Zhang, B., Shi, Z., Duncan, D. T., Prodduturi, N., Marnett, L. J. and Liebler, D. C. (2011) Relating protein adduction to gene expression changes: a systems approach. Mol. Biosyst. 7, 2118-2127
139. Kim, H. Y., Tallman, K. A., Liebler, D. C. and Porter, N. A. (2009) An azido-biotin reagent for use in the isolation of protein adducts of lipid-derived electrophiles by streptavidin catch and photorelease. Mol. Cell. Proteomics 8, 2080-2089
140. Landar, A., Shiva, S., Levonen, A. L., Oh, J. Y., Zaragoza, C., Johnson, M. S. and Darley-Usmar, V. M. (2006) Induction of the permeability transition and cytochrome c release by 15-deoxy-Δ12,14-prostaglandin J2 in mitochondria. Biochem. J. 394, 185-195 (Pubitemid 43259668)
141. Roberts, II, L. J. and Fessel, J. P. (2004) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem. Phys. Lipids 128, 173-186 (Pubitemid 38167386)
142. Trachootham, D., Lu, W., Ogasawara, M. A., Nilsa, R. D. and Huang, P. (2008) Redox regulation of cell survival. Antioxid. Redox Signaling 10, 1343-1374
143. Satoh, T. and Lipton, S. A. (2007) Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci. 30, 37-45 (Pubitemid 44960491)
144. Claiborne, A., Yeh, J. I., Mallett, T. C., Luba, J., Crane, III, E. J., Charrier, V. and Parsonage, D. (1999) Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38, 15407-15416
145. McMahon, M., Lamont, D. J., Beattie, K. A. and Hayes, J. D. (2010) Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. U.S.A. 107, 18838-18843
146. Murphy, M. P. (2011) Mitochondrial thiols in antioxidant protection and redox signalling: distinct roles for glutathionylation and other thiol modifications. Antioxid. Redox Signaling, doi:10.1089/ars.2011.4289
147. Wong, H. L. and Liebler, D. C. (2008) Mitochondrial protein targets of thiol-reactive electrophiles. Chem. Res. Toxicol. 21, 796-804 (Pubitemid 351644557)
148. Meng, T. C., Fukada, T. and Tonks, N. K. (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387-399 (Pubitemid 34195563)
149. Diers, A. R., Dranka, B. P., Ricart, K. C., Oh, J. Y., Johnson, M. S., Zhou, F., Pallero, M. A., Bodenstine, T. M., Murphy-Ullrich, J. E., Welch, D. R. and Landar, A. (2010) Modulation of mammary cancer cell migration by 15-deoxy-Δ(12,14)-prostaglandin J2: implications for anti-metastatic therapy. Biochem. J. 430, 69-78
150. Levonen, A. L., Dickinson, D. A., Moellering, D. R., Mulcahy, R. T., Forman, H. J. and Darley-Usmar, V. M. (2001) Biphasic effects of 15-deoxy-Δ(12,14)-prostaglandin J2 on glutathione induction and apoptosis in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 21, 1846-1851 (Pubitemid 34219791)
151. Requejo, R., Hurd, T. R., Costa, N. J. and Murphy, M. P. (2010) Cysteine residues exposed on protein surfaces are the dominant intramitochondrial thiol and may protect against oxidative damage. FEBS J. 277, 1465-1480
152. Sheehan, D., Meade, G., Foley, V. M. and Dowd, C. A. (2001) Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 360, 1-16 (Pubitemid 33081943)
153. Niture, S. K. and Jaiswal, A. K. (2011) Inhibitor of Nrf2 (INrf2 or Keap1) degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis. J. Biol. Chem. 286, 44542-44556
154. Landar, A., Zmijewski, J. W., Dickinson, D. A., Le Goffe, C., Johnson, M. S., Milne, G. L., Zanoni, G., Vidari, G., Morrow, J. D. and Darley-Usmar, V. M. (2006) Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 290, H1777-H1787
155. Kondo, M., Shibata, T., Kumagai, T., Osawa, T., Shibata, N., Kobayashi, M., Sasaki, S., Iwata, M., Noguchi, N. and Uchida, K. (2002) 15-Deoxy-Δ(12,14)-prostaglandin J2: the endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 99, 7367-7372 (Pubitemid 34568697)
156. Diers, A. R., Higdon, A. N., Ricart, K. C., Johnson, M. S., Agarwal, A., Kalyanaraman, B., Landar, A. and Darley-Usmar, V. M. (2010) Mitochondrial targeting of the electrophilic lipid 15-deoxy-Δ12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. Biochem. J. 426, 31-41
157. Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A., Osipov, A. N., Belikova, N. A., Kapralov, A. A., Kini, V. et al. (2005) Cytochrome cacts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1, 223-232
158. Morimitsu, Y., Nakagawa, Y., Hayashi, K., Fujii, H., Kumagai, T., Nakamura, Y., Osawa, T., Horio, F., Itoh, K., Iida, K. et al. (2002) A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J. Biol. Chem. 277, 3456-3463 (Pubitemid 34953214)
159. Li, Y., Cao, Z. and Zhu, H. (2006) Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res. 53, 6-15 (Pubitemid 41619373)
160. Kansanen, E., Jyrkkanen, H. K., Volger, O. L., Leinonen, H., Kivela, A. M., Hakkinen, S. K., Woodcock, S. R., Schopfer, F. J., Horrevoets, A. J., Yla-Herttuala, S. et al. (2009) Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid. J. Biol. Chem. 284, 33233-33241
161. Powers, M. V. and Workman, P. (2007) Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett. 581, 3758-3769 (Pubitemid 47081010)
162. Mosser, D. D., Theodorakis, N. G. and Morimoto, R. I. (1988) Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. Mol. Cell. Biol. 8, 4736-4744 (Pubitemid 18261551)
163. Shi, Y., Mosser, D. D. and Morimoto, R. I. (1998) Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev. 12, 654-666 (Pubitemid 28134298)
164. Fujimoto, M. and Nakai, A. (2010) The heat shock factor family and adaptation to proteotoxic stress. FEBS J. 277, 4112-4125
165. Bocci, V., Aldinucci, C., Mosci, F., Carraro, F. and Valacchi, G. (2007) Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflammation 2007, 26785
166. Yu, Z., Yang, X. and Wang, K. (2006) Metal ions induced heat shock protein response by elevating superoxide anion level in HeLa cells transformed by HSE-SEAP reporter gene. Toxicology 223, 1-8 (Pubitemid 43728623)
167. Barrett, W. C., DeGnore, J. P., Konig, S., Fales, H. M., Keng, Y. F., Zhang, Z. Y., Yim, M. B. and Chock, P. B. (1999) Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38, 6699-6705
168. Murry, C. E., Jennings, R. B. and Reimer, K. A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136 (Pubitemid 17174962)
169. Reimer, K. A., Murry, C. E. and Jennings, R. B. (1990) Cardiac adaptation to ischemia. Ischemic preconditioning increases myocardial tolerance to subsequent ischemic episodes. Circulation 82, 2266-2268
170. Starkopf, J., Andreasen, T. V., Bugge, E. and Ytrehus, K. (1998) Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart. Cardiovasc. Res. 37, 66-75 (Pubitemid 28122617)
171. Tritto, I. and Ambrosio, G. (2001) Role of oxidants in the signaling pathway of preconditioning. Antiox. Redox Signaling 3, 3-10 (Pubitemid 32240625)
172. Xu, B., Gao, X., Xu, J., Lei, S., Xia, Z. Y., Xu, Y. and Xia, Z. (2011) Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase 1. J. Surg. Res. 166, e157-e164
173. Patel, A., van de Poll, M. C., Greve, J. W., Buurman, W. A., Fearon, K. C., McNally, S. J., Harrison, E. M., Ross, J. A., Garden, O. J., Dejong, C. H. and Wigmore, S. J. (2004) Early stress protein gene expression in a human model of ischemic preconditioning. Transplantation 78, 1479-1487 (Pubitemid 39552934)
174. Jancso, G., Cserepes, B., Gasz, B., Benko, L., Borsiczky, B., Ferenc, A., Kurthy, M., Racz, B., Lantos, J., Gal, J. et al. (2007) Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning. Ann. N.Y. Acad. Sci. 1095, 251-261 (Pubitemid 47092457)
175. Zou, Y., Zhu, W., Sakamoto, M., Qin, Y., Akazawa, H., Toko, H., Mizukami, M., Takeda, N., Minamino, T., Takano, H. et al. (2003) Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury. Circulation 108, 3024-3030 (Pubitemid 37553573)
176. Liu, Y., Kato, H., Nakata, N. and Kogure, K. (1993) Temporal profile of heat shock protein 70 synthesis in ischemic tolerance induced by preconditioning ischemia in rat hippocampus. Neuroscience 56, 921-927 (Pubitemid 23308647)
177. Tsuruma, T., Yagihashi, A., Matsuno, T., Zou, X. M., Asanuma, K., Sasaki, K. and Hirata, K. (1996) The heat-shock protein 70 family reduces ischemia/reperfusion injury in small intestine. Transplant. Proc. 28, 2629-2630 (Pubitemid 26339425)
178. Kume, M., Yamamoto, Y., Saad, S., Gomi, T., Kimoto, S., Shimabukuro, T., Yagi, T., Nakagami, M., Takada, Y., Morimoto, T. and Yamaoka, Y. (1996) Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J. Lab. Clin. Med. 128, 251-258 (Pubitemid 27506936)
179. Pagel, P. S. (2008) Induction of heat shock protein 70 and preconditioning by sevoflurane: a potent protective interaction against myocardial ischemia-reperfusion injury. Anesth. Analg. 107, 742-745
180. Straus, D. S. and Glass, C. K. (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21, 185-210 (Pubitemid 32303994)
181. Watanabe, N., Zmijewski, J. W., Takabe, W., Umezu-Goto, M., Le Goffe, C., Sekine, A., Landar, A., Watanabe, A., Aoki, J., Arai, H. et al. (2006) Activation of mitogen-activated protein kinases by lysophosphatidylcholine- induced mitochondrial reactive oxygen species generation in endothelial cells. Am. J. Pathol. 168, 1737-1748
182. Hill, B. G., Haberzettl, P., Ahmed, Y., Srivastava, S. and Bhatnagar, A. (2008) Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochem. J. 410, 525-534 (Pubitemid 351429023)
183. Cernuda-Morollon, E., Pineda-Molina, E., Canada, F. J. and Perez-Sala, D. (2001) 15-Deoxy-Δ12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit. J. Biol. Chem. 276, 35530-35536
184. Oliva, J. L., Perez-Sala, D., Castrillo, A., Martinez, N., Canada, F. J., Bosca, L. and Rojas, J. M. (2003) The cyclopentenone 15-deoxy-Δ12,14- prostaglandin J2 binds to and activates H-Ras. Proc. Natl. Acad. Sci. U.S.A. 100, 4772-4777 (Pubitemid 36469241)
185. Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J. and Uchida, K. (2003) Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 278, 26046-26054 (Pubitemid 36835372)
186. Cassidy, P. B., Edes, K., Nelson, C. C., Parsawar, K., Fitzpatrick, F. A. and Moos, P. J. (2006) Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27, 2538-2549 (Pubitemid 44884113)
187. Perez-Sala, D., Cernuda-Morollon, E. and Canada, F. J. (2003) Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Δ12,14- prostaglandin J2. J. Biol. Chem. 278, 51251-51260 (Pubitemid 38020362)
188. Gayarre, J., Sanchez, D., Sanchez-Gomez, F. J., Terron, M. C., Llorca, O. and Perez-Sala, D. (2006) Addition of electrophilic lipids to actin alters filament structure. Biochem. Biophys. Res. Commun. 349, 1387-1393 (Pubitemid 44416410)
189. Aldini, G., Dalle-Donne, I., Vistoli, G., Maffei Facino, R. and Carini, M. (2005) Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction. J. Mass Spectrom. 40, 946-954 (Pubitemid 41098081)
190. Ishii, T., Sakurai, T., Usami, H. and Uchida, K. (2005) Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry 44, 13893-13901 (Pubitemid 41507469)
191. Waku, T., Shiraki, T., Oyama, T., Fujimoto, Y., Maebara, K., Kamiya, N., Jingami, H. and Morikawa, K. (2009) Structural insight into PPARγ activation through covalent modification with endogenous fatty acids. J. Mol. Biol. 385, 188-199
192. Vieira, H. L., Belzacq, A. S., Haouzi, D., Bernassola, F., Cohen, I., Jacotot, E., Ferri, K. F., El Hamel, C., Bartle, L. M., Melino, G. et al. (2001) The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20, 4305-4316 (Pubitemid 32726872)
193. Yarian, C. S., Rebrin, I. and Sohal, R. S. (2005) Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. Biochem. Biophys. Res. Commun. 330, 151-156 (Pubitemid 40394947)
194. Kaplan, P., Tatarkova, Z., Racay, P., Lehotsky, J., Pavlikova, M. and Dobrota, D. (2007) Oxidative modifications of cardiac mitochondria and inhibition of cytochrome c oxidase activity by 4-hydroxynonenal. Redox Rep. 12, 211-218 (Pubitemid 350065108)
195. Chen, J., Robinson, N. C., Schenker, S., Frosto, T. A. and Henderson, G. I. (1999) Formation of 4-hydroxynonenal adducts with cytochrome c oxidase in rats following short-term ethanol intake. Hepatology 29, 1792-1798 (Pubitemid 29247053)
196. Chen, J., Schenker, S., Frosto, T. A. and Henderson, G. I. (1998) Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim. Biophys. Acta 1380, 336-344 (Pubitemid 28210348)